CNS Pharmaceuticals, Inc. (CNSP) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.10M | +62.5% |
| 2024 | $2.52M | -58.8% |
| 2023 | $6.13M | +24.6% |
| 2022 | $4.92M | +89.7% |
| 2021 | $2.59M | +36.1% |
| 2020 | $1.91M | +512.7% |
| 2019 | $311.0K | -74.8% |
| 2018 | $1.23M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.10M | +62.5% |
| 2024 | $2.52M | -58.8% |
| 2023 | $6.13M | +24.6% |
| 2022 | $4.92M | +89.7% |
| 2021 | $2.59M | +36.1% |
| 2020 | $1.91M | +512.7% |
| 2019 | $311.0K | -74.8% |
| 2018 | $1.23M | — |